New York, Global Infectious Disease Diagnostics Market was valued at USD 35.5 billion in 2021 and it is anticipated to grow further up to USD 30.9 billion by 2031, at a CAGR of -1.4% during the forecast period.
The infectious diseases diagnostics market report from Global Insight Services is the single authoritative source of intelligence on Infectious Disease Diagnostics Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
A contagious illness A diagnostic is a laboratory test carried out by trained technicians and medical professionals to identify infectious diseases. It is a diagnostic process used to characterize and identify the infectious disease’s causal organism. By using a variety of diagnostic techniques and tools, the sample of urine, blood, mucus, or other body fluids is examined to provide details on the causative organism.
Request sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10304/
Market Trends and Drivers
The market for infectious disease diagnostics will rise as a result of the prevalence of infectious diseases in both developed and emerging nations. The growing number of prescriptions for infectious illness diagnostic tests is due to the diagnosis and treatment of such disorders. The demand for infectious disease diagnostics is anticipated to increase during the projected period as a result of these factors and the expanding trend toward preventive medicine. The extensive population-based testing is necessary to enhance COVID-19 preventive and control activities. Since infectious disease diagnostics performs these tests, it had a favorable effect on this market.
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10304/
Global Infectious Disease Diagnostics Market Segmental Overview
The report analyses the global infectious diseases diagnostics market based on the products & services, technology, disease type, end-use, and region.
Global Infectious Disease Diagnostics Market by Products & Services
Based on the products & services, it is segmented into assays, kits & reagents, instruments, services & software. The assays, kits & reagents segment is anticipated to dominate the market during the forecast period. Due to an increase in research and development (R&D) activities in the pharmaceutical and biotechnology industries, a rise in reagent demand, and a surge in the use of point-of-care testing. However, the instruments market is anticipated to expand significantly over the course of the forecast period due to an increase in research laboratories and increased funding from public and commercial organizations for the creation of diagnostic tools for the pharmaceutical and biotechnology sectors.
Global Infectious Disease Diagnostics Market by Technology
Based on the technology, it is segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & next generation sequencing, DNA Microarray, and others. The polymerase chain reaction segment is anticipated to dominate the market during the forecast period. Mostly as a result of the coronavirus pandemic’s rapid spread. Since the COVID-19 outbreak, the use of reverse transcription polymerase chain reaction (RT-PCR) diagnostic testing has rapidly increased around the world. The pandemic’s ongoing nature and the appearance of new variations indicate that need for PCR diagnostic solutions will persist in the ensuing years.
Global Infectious Disease Diagnostics Market by Disease Type
Based on the disease type, it is segmented into hepatitis, human immunodeficiency virus, chlamydia trachomatis genital infection and gonorrhea, hospital-acquired infection, human papillomavirus, tuberculosis, influenza, and others. The hepatitis segment is anticipated to dominate the market during the forecast period. Growing numbers of blood donors and transfusions are a major contributing factor to the illness, which can be treated if detected early. The senior population’s high susceptibility and rising public awareness of hepatitis will continue to fuel demand for hepatitis diagnostic tools.
Global Infectious Disease Diagnostics Market by End User
Based on the end user, it is segmented into hospitals/clinical laboratories, reference laboratories, and others. The hospitals/clinical laboratories segment is likely to dominate the market during the forecast period. The key factors such as rising technological advancements in infectious disease diagnostics coupled with a shift in focus from centralized laboratories to decentralize POC testing are boosting the growth of the market.
Geographical Analysis of the Global Infectious Disease Diagnostics Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is anticipated to dominate the market during the forecast period. Government and healthcare organizations are investing more on infrastructure, upgrades, and the need to deal with the growing burden of infectious diseases. Numerous initiatives have been done by the regional governments to increase the accessibility of diagnostic services. A better regulatory environment that requires infectious disease testing will improve the prognosis for the region.
Major Players in the Global Infectious Disease Diagnostics Market
The key players studied in the report are Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Siemens Healthineers AG (Germany), Danaher Corporation (US), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Hologic, Inc. (US), QIAGEN N.V. (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), and Ortho Clinical Diagnostics Holdings plc (US), among others.
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10304/
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700